TriSalus Life Sciences, Inc. — Form D

TriSalus Life Sciences, Inc. of WESTMINSTER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-08. The offering totals $22.0M, of which $22.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (36)

Showing 25 of 36 people.

NameRoleLocation
Arjun F DesaiDirectorWestminster, CO
Gary F GordonDirectorWestminster, CO
Kerry F HicksDirectorWestminster, CO
David J MatlinDirectorWestminster, CO
Sean MurphyDirectorSan Diego, CA
Mary SzelaDirectorWestminster, CO
William F ValleDirectorWestminster, CO
Andrew F von EschenbachDirectorWestminster, CO
Mats J WahlstromDirectorBuffalo, NY
Brian F CoxExecutive OfficerWestminster, CO
Jodi J DevlinExecutive OfficerWestminster, CO
Richard J MarshakExecutive OfficerWestminster, CO
Jennifer J StevensExecutive OfficerWestminster, CO
Mary SzelaExecutive OfficerWestminster, CO
James YoungExecutive OfficerWestminster, CO
Karim KartiDirectorMenlo Park, CA
David J MatlinExecutive OfficerWestminster, CO
Sean MurphyExecutive OfficerSan Diego, CA
Kerry B HicksDirectorWestminster, CO
Jennifer E StevensExecutive OfficerWestminster, CO
Mats Kelly WahlstromDirectorWestminster, CO
Richard B MarshakExecutive OfficerWestminster, CO
Liselotte B HyveledDirectorWestminster, CO
David Kelly MatlinDirectorWestminster, CO
Jodi Kelly DevlinExecutive OfficerWestminster, CO

Other filings by this issuer (2)

FiledFormOfferingSold
2024-12-30D$1000K$1000K
2023-06-22D$50.0M$17.9M

More